"No clinical benefit From the Use of Hydroxychloroquine"? Wrong!... OXFORD IS WRONG!
First ptient enrolled in new clinical trial of possible COVID-19 treatments.
Image credit: Shutterstock
No clinical benefit from use of hydroxychloroquine in hospitalized patients with COVID-19 [My comments in red j. ramirez]
A new statement has been released from the Chief Investigators of the Randomised Evaluation of COVid-19 THERAPY (RECOVERY) Trial on hydroxychloroquine.
Professor Peter Horby and Professor Martin Landray,
Two "scientists" that are totally wrong or very corrupt and apparently rule in the United Kingdom just like that funest Fauci in the USA
https://bit.ly/OxfordPseudoTrial
Below an interesting Twitter exchange
These two are the same birds that now are lying about Ivermectin and apparently have enough power to stop other Doctors from using it: See below (I believe they are definitely CORRUPT),
But back to their fake hydroxychloroquine trial report...
Chief investigators of the RECOVERY Trial, said ‘In March this year, RECOVERY was established as a randomized clinical trial to test a range of potential drugs for COVID-19, including hydroxychloroquine. HCQ is one of the 3 components of the Zelenko Protocol, it works in synergy with Zinc and an antibiotic, NOT intended to be used by itself against Covid19
Look at the upper right corner:
1. Zinc is the key, Inhibits Virus RNA POLYMERASE, transcription, translation, virus multiplication
How Enzymes work, excellent simulation Zinc inhibits RNA Polymerase, DNA DOES NOT OPEN, the virus can't replicate, am I the first to explain this? Please tell me if I'm wrong, I want no problems with mary Poppins. The spreaders of misinformation are the WHO and the FDA. in complicity with fake news
2. Hydroxychloroquine carries the Zinc inside the cell (is a Zinc ionophore). Important: There are other Zinc ionophores available
3. Azithromycin is an antibiotic, others can be used
It is easy to understand if you want to understand, why such determined opposition? I smell a rat here (two rats that will destroy Oxford's prestige.
Unfortunately, they don't seem to know how to use hydroxychloroquine which is a zinc ionophore (despite the fact that Oxford teaches "molecular biology")
‘The trial has proceeded at unprecedented speed, enrolling over 11,000 patients from 175 NHS hospitals in the UK. Throughout this time, the independent Data Monitoring Committee has reviewed the emerging data about every two weeks to determine if there is evidence that would be strong enough to affect national and global [global?] treatment of COVID-19.
‘On Thursday 4 June, in response to a request from the UK Medicines and Healthcare Products Regulatory Agency (MHRA), the independent how independent? Data Monitoring Committee conducted a further review of the data. Last night, the Committee recommended the chief investigators review the unblinded data on the hydroxychloroquine arm of the trial.
‘We have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalized with COVID-19. We have therefore decided to stop enrolling participants in the hydroxychloroquine arm of the RECOVERY trial with immediate effect. We are now releasing the preliminary results as they have important implications for patient care and public health.
‘A total of 1542 patients were randomized to hydroxychloroquine and compared with 3132 patients randomized to usual care ? alone. There was no significant difference in the primary endpoint of 28-day mortality (25.7% hydroxychloroquine vs. 23.5% usual care; hazard ratio 1.11 [95% confidence interval 0.98-1.26]; p=0.10). There was also no evidence of beneficial effects on hospital stay duration or other outcomes. Where is the Zinc? Don't you know that the #HCQ is used to get the Zinc inside the cell?
‘These data convincingly rule out any meaningful mortality benefit of hydroxychloroquine in patients hospitalized with COVID-19. Full results will be made available as soon as possible.
Peter Horby, Professor of Emerging Infectious Diseases and Global Health in the Nuffield Department of Medicine, University of Oxford, and Chief Investigator for the trial, said: ‘Hydroxychloroquine and chloroquine have received a lot of attention and have been used very widely to treat COVID patients despite the absence of any good evidence. That is false, if you don't want to see it you won't see it. The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19. Although it is disappointing that this treatment has been shown to be ineffective, it does allow us to focus care and research on more promising drugs.’
What is disappointing is the fact that you and your prestigious institution don't know how to use a Zinc Ionophore (there are others, why did you stop research?)
Martin Landray, Professor of Medicine and Epidemiology at the Nuffield Department of Population Health, University of Oxford, and Deputy Chief Investigator, said, ‘There has been huge speculation and uncertainty about the role of hydroxychloroquine as a treatment for COVID-19, but an absence of reliable information from large randomized trials. Today’s preliminary results from the RECOVERY trial are quite clear – hydroxychloroquine does not reduce the risk of death among hospitalized patients (The Zelenko Protocol is not intended for hospitalized patients) with this new disease. This result should change medical practice worldwide and demonstrates the importance of large, randomised trials to inform decisions about both the efficacy and the safety of treatments.’It is unethical to wait till the patient's lungs are seriously infected and require hospitalization to start treament. You don't wait till half of the house is in flames to call the firemen, DO YOU?
Full details of the study protocol and related materials are available at www.recoverytrial.net
NOT TREATING THE PATIENT IMMEDIATELY WITH THE LATEST TREATMENT AVAILABLE CONSTITUTES MEDICAL MALPRACTICE AND I ADVISE THE RELATIVES OF VICTIMS TO SUE. THIS CAN'T BE ALLOWED TO HAPPEN AGAIN
Juan J. Ramirez
